167.10
3.55 (2.17%)
| Previous Close | 163.55 |
| Open | 161.61 |
| Volume | 237,556 |
| Avg. Volume (3M) | 545,686 |
| Market Cap | 9,029,281,792 |
| Price / Sales | 4.74 |
| Price / Book | 9.55 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 12 May 2025 |
| Profit Margin | -14.56% |
| Operating Margin (TTM) | -9.09% |
| Diluted EPS (TTM) | -5.72 |
| Quarterly Revenue Growth (YOY) | 9.40% |
| Quarterly Earnings Growth (YOY) | -7.50% |
| Total Debt/Equity (MRQ) | 80.43% |
| Current Ratio (MRQ) | 1.98 |
| Operating Cash Flow (TTM) | 196.40 M |
| Levered Free Cash Flow (TTM) | 153.82 M |
| Return on Assets (TTM) | 0.61% |
| Return on Equity (TTM) | -25.23% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Masimo Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.38 |
|
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 8.51% |
| % Held by Institutions | 96.70% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 215.00 (Piper Sandler, 28.67%) | Buy |
| Median | 210.00 (25.67%) | |
| Low | 205.00 (Wells Fargo, 22.68%) | Buy |
| Average | 210.00 (25.67%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 190.47 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 26 Feb 2025 | 215.00 (28.67%) | Buy | 190.47 |
| Wells Fargo | 26 Feb 2025 | 205.00 (22.68%) | Buy | 190.47 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Apr 2025 | Announcement | Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference |
| 28 Feb 2025 | Announcement | Masimo to Present in the 46th Annual Raymond James Institutional Investor Conference |
| 25 Feb 2025 | Announcement | Masimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 Guidance |
| 21 Jan 2025 | Announcement | Masimo Announces Leadership Transition |
| 16 Jan 2025 | Announcement | Masimo Announces Select Preliminary 2024 Financial Results and 2025 Guidance |
| 08 Jan 2025 | Announcement | Masimo to Present in the 43rd Annual J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |